Opinion|Videos|September 29, 2026

Monitoring Treatment Response and Adapting Care in Achondroplasia

Response to growth-modulating therapy may evolve over several years. Structured monitoring helps clinicians assess benefit, manage expectations, and adapt treatment and orthopedic care when needed.

This episode, titled “Monitoring Treatment Response and Adapting Care in Achondroplasia,” features panelists discussing how they follow children receiving growth-modulating therapy and determine whether management should change over time. The panel emphasizes that response should not necessarily be judged after a single year. Some children may demonstrate greater improvement during the second year of therapy, making longitudinal follow-up important before concluding that treatment has been ineffective. The experts describe regular visits that include achondroplasia-specific growth curves and measurements such as height, sitting height, arm span, body segment measurements, and weight.

Maintaining open growth plates is also central to treatment response, and the panel discusses monitoring epiphyseal status as children approach skeletal maturity. Rather than immediately labeling children who show limited initial improvement as “non-responders,” the experts prefer to recognize that some may simply respond more slowly. The conversation then turns to orthopedic care. Existing surveillance for kyphosis, spinal disease, and lower-extremity abnormalities remains necessary regardless of pharmacologic treatment. In some cases, growth modulation may influence how long guided-growth hardware remains in place, requiring closer orthopedic follow-up.

The panel also discusses limb lengthening. Their clinical experience highlights potential complications, including pain, altered gait, changes in function, and significant financial and treatment burden. The availability of pharmacologic growth-modulating therapies now adds another consideration when families weigh whether to pursue these procedures.

In the next episode, “Supporting Long-Term Health, Independence, and Well-Being in Achondroplasia,” the panel will broaden the discussion beyond treatment monitoring. They will explore unanswered questions, healthy weight, daily independence, and the social and emotional challenges children may encounter as they grow.


Related to this article